Skip to main content
Search

Zunyi Medical University

1 related articles

Subscribe to updates
  1. Closing AI drug-regulatory gaps through harmonized oversight

    The article notes that while artificial intelligence accelerates drug discovery it also creates regulatory gaps, with more than 100 AI-assisted pipelines in trials and frameworks lacking enforceable standards; it therefore proposes a risk-tiered framework that distinguishes discovery AI from evidence-generating AI, mandates impact assessments and Investigational New Drug disclosure when AI influences decisions, and transforms guidelines into binding, risk-proportionate regulation.

You’re all caught up